Jessica Glick, DO
Family Medicine · Houston, TXNPI 1114375227
Payments from drug & device makers
Across 187 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$707
- Novo Nordisk$463
- Lilly USA, LLC$374
- AstraZeneca$297
- Inspire Medical Systems, Inc.$265
- Amgen$233
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,759100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $707 |
| Novo Nordisk | 26 | $463 |
| Lilly USA, LLC | 19 | $374 |
| AstraZeneca | 13 | $297 |
| Inspire Medical Systems, Inc. | 3 | $265 |
| Amgen | 8 | $233 |
| Bayer | 6 | $152 |
| Paratek Pharmaceuticals, Inc. | 10 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Biohaven Pharmaceuticals, Inc. | 5 | $118 |
| Daiichi Sankyo Inc. | 4 | $94 |
| Romark Laboratories, LC | 2 | $88 |
| Astellas Pharma US Inc | 4 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Merck | 4 | $57 |
| Johnson & Johnson | 4 | $56 |
| GSK | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| Amarin Pharma, Inc. | 2 | $44 |
| Abbott | 2 | $38 |
| Bioventus LLC | 1 | $33 |
| Novartis | 2 | $32 |
| Boehringer Ingelheim | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Therapeuticsmd, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Pfizer | 1 | $20 |
| ERMI LLC | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,773 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 93 | $1,022 |
| Lamotrigine ErLamotrigine | 11 | $948 |
| Potassium Chloride | 12 | $860 |
| Rosuvastatin Calcium | 47 | $764 |
| Gabapentin | 12 | $689 |
| Atorvastatin Calcium | 68 | $662 |
| Omeprazole | 35 | $625 |
| Pantoprazole Sodium | 34 | $489 |
| Amlodipine Besylate | 55 | $477 |
| Tamsulosin Hcl | 25 | $470 |
| Lisinopril | 52 | $460 |
| Ezetimibe | 25 | $444 |
| Trazodone Hcl | 28 | $393 |
| Metoprolol Succinate | 31 | $383 |
| Pravastatin Sodium | 14 | $321 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Houston
- Lisa HollowayHouston$30.1M
- Veronica FragosoHouston$24.5M
- Bonnie ColvilleHouston$19.6M
- Oscar de ValleHouston$12.8M
- van TranHouston$11M
- Joe PouzarHouston$10.7M
- Aalia Al-BarwaniHouston$6.8M
- Terence ChangHouston$3.3M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.